caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1164723508

Myrna Andino-CamachoMD

Hematology-OncologyBayamon, PRI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
Final MIPS score
72.0
Quality
40.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
-0.36%
Group
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 400104
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
1,086
Beneficiaries
—
Total drug cost
$4.1M
Distinct drugs
34
Brand share
29.7%
Top prescribed drugs
Anastrozole333 claims
Dexamethasone71 claims
Famotidine50 claims
Tramadol Hcl35 claims
Osimertinib Mesylate33 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$3K
Payment records
123
By payment type
Food and Beverage$3K
Education$70
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
11
Unique beneficiaries
—
Total services
28
Distinct HCPCS
1
Medicare payment
$2K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 71 Hematology-Oncology providers in PR — bottom quintile (cohort median 980).